Simon Lee, MD
Foot and Ankle Surgery · Chicago, ILNPI 1922087691
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,070 of the $34,361 with a category attached, or 75.9%. Amgen accounts for 76.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $28,501 and has fallen 96.2% since, to $1,097 in 2025. Among foot and ankle surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $582.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$26K
- Stryker$4K
- Arthrex$2K
- Medwest Associates$851
- Fusion Orthopedics USA, LLC$446
- Lightbody Medical Technologies Inc$416
- plus $473 from 5 others
Across 11 payments — averaging $4683.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring International Pharmascience Center US$31K
- DJO, LLC$21K
What the payments were for
- Consulting fees$26,07076%
- Travel & lodging$2,0656%
- Food & beverage$4,15612%
- Education$2,0716%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 2 | $26,109 |
| Stryker(2 entities) | 37 | $4,429 |
| Arthrex | 1 | $1,636 |
| Medwest Associates | 5 | $851 |
| Fusion Orthopedics USA, LLC | 2 | $446 |
| Lightbody Medical Technologies Inc | 3 | $416 |
| Johnson & Johnson | 3 | $190 |
| Novastep Inc. | 2 | $163 |
| Paragon 28, Inc. | 2 | $68 |
| Smith+Nephew | 1 | $28 |
| Vericel Corporation | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$24,070
- INFINITY$2,600
- INBONE$395
- XARELTO$147
- AUGMENT$145
- TRAUMA$136
- ALLOMATRIX$134
- Actishield$109
- AUGMENT INJECTABLE$104
How this compares
$34,361 in reported general payments places this provider in the 90th percentile of 555 foot and ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $376 |
| Ondansetron Hcl | 37 | $272 |
| Cephalexin | 32 | $77 |
| Meloxicam | 25 | $44 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Chicago
- Edgardo Rodriguez CollazoChicago$755K
- Stephanie OexemanChicago$206K
- Jeffrey AlexanderChicago$158K
- Matthew GaroufalisChicago$151K
- George HolmesChicago$134K
- Milap PatelChicago$52K
- Theodore PolizosChicago$47K
- Wonyong LeeChicago$23K
- Kamran HamidChicago$19K
- Souleymane DialloChicago$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.